Table of Contents

2018-2023 Global Zika Vaccines Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Zika Vaccines Consumption 2013-2023
  • 2.1.2 Zika Vaccines Consumption CAGR by Region
• 2.2 Zika Vaccines Segment by Type
  • 2.2.1 Therapeutic Vaccines
  • 2.2.2 Preventive Vaccines
• 2.3 Zika Vaccines Consumption by Type
  • 2.3.1 Global Zika Vaccines Consumption Market Share by Type (2013-2018)
  • 2.3.2 Global Zika Vaccines Revenue and Market Share by Type (2013-2018)
  • 2.3.3 Global Zika Vaccines Sale Price by Type (2013-2018)
• 2.4 Zika Vaccines Segment by Application
  • 2.4.1 Hospitals
  • 2.4.2 Clinics
  • 2.4.3 Ambulatory Surgery Centers
  • 2.4.4 Others
• 2.5 Zika Vaccines Consumption by Application
  • 2.5.1 Global Zika Vaccines Consumption Market Share by Application (2013-2018)
  • 2.5.2 Global Zika Vaccines Value and Market Share by Application (2013-2018)
  • 2.5.3 Global Zika Vaccines Sale Price by Application (2013-2018)

3 Global Zika Vaccines by Players

• 3.1 Global Zika Vaccines Sales Market Share by Players
  • 3.1.1 Global Zika Vaccines Sales by Players (2016-2018)
  • 3.1.2 Global Zika Vaccines Sales Market Share by Players (2016-2018)
• 3.2 Global Zika Vaccines Revenue Market Share by Players
  • 3.2.1 Global Zika Vaccines Revenue by Players (2016-2018)
  • 3.2.2 Global Zika Vaccines Revenue Market Share by Players (2016-2018)
• 3.3 Global Zika Vaccines Sale Price by Players
• 3.4 Global Zika Vaccines Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Zika Vaccines Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Zika Vaccines Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Zika Vaccines by Regions

• 4.1 Zika Vaccines by Regions
  • 4.1.1 Global Zika Vaccines Consumption by Regions
  • 4.1.2 Global Zika Vaccines Value by Regions
• 4.2 Americas Zika Vaccines Consumption Growth
• 4.3 APAC Zika Vaccines Consumption Growth
• 4.4 Europe Zika Vaccines Consumption Growth
• 4.5 Middle East & Africa Zika Vaccines Consumption Growth

5 Americas

• 5.1 Americas Zika Vaccines Consumption by Countries
  • 5.1.1 Americas Zika Vaccines Consumption by Countries (2013-2018)
  • 5.1.2 Americas Zika Vaccines Value by Countries (2013-2018)
• 5.2 Americas Zika Vaccines Consumption by Type
• 5.3 Americas Zika Vaccines Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Zika Vaccines Consumption by Countries
  • 6.1.1 APAC Zika Vaccines Consumption by Countries (2013-2018)
  • 6.1.2 APAC Zika Vaccines Value by Countries (2013-2018)
• 6.2 APAC Zika Vaccines Consumption by Type
• 6.3 APAC Zika Vaccines Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Zika Vaccines by Countries
  • 7.1.1 Europe Zika Vaccines Consumption by Countries (2013-2018)
  • 7.1.2 Europe Zika Vaccines Value by Countries (2013-2018)
• 7.2 Europe Zika Vaccines Consumption by Type
• 7.3 Europe Zika Vaccines Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Zika Vaccines by Countries
  • 8.1.1 Middle East & Africa Zika Vaccines Consumption by Countries (2013-2018)
  • 8.1.2 Middle East & Africa Zika Vaccines Value by Countries (2013-2018)
• 8.2 Middle East & Africa Zika Vaccines Consumption by Type
• 8.3 Middle East & Africa Zika Vaccines Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.2 Zika Vaccines Distributors
• 10.3 Zika Vaccines Customer

11 Global Zika Vaccines Market Forecast

• 11.1 Global Zika Vaccines Consumption Forecast (2018-2023)
• 11.2 Global Zika Vaccines Forecast by Regions
  • 11.2.1 Global Zika Vaccines Forecast by Regions (2018-2023)
  • 11.2.2 Global Zika Vaccines Value Forecast by Regions (2018-2023)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Zika Vaccines Forecast by Type
• 11.8 Global Zika Vaccines Forecast by Application

12 Key Players Analysis

• 12.1 Bharat Biotech
  • 12.1.1 Company Details
  • 12.1.2 Zika Vaccines Product Offered
  • 12.1.3 Bharat Biotech Zika Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.1.4 Main Business Overview
  • 12.1.5 Bharat Biotech News
• 12.2 Inovio Pharmaceuticals
  • 12.2.1 Company Details
  • 12.2.2 Zika Vaccines Product Offered
  • 12.2.3 Inovio Pharmaceuticals Zika Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.2.4 Main Business Overview
  • 12.2.5 Inovio Pharmaceuticals News
• 12.3 Cerus Corporation
  • 12.3.1 Company Details
  • 12.3.2 Zika Vaccines Product Offered
  • 12.3.3 Cerus Corporation Zika Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.3.4 Main Business Overview
  • 12.3.5 Cerus Corporation News
• 12.4 Sanofi
  • 12.4.1 Company Details
  • 12.4.2 Zika Vaccines Product Offered
  • 12.4.3 Sanofi Zika Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.4.4 Main Business Overview
  • 12.4.5 Sanofi News
• 12.5 NewLink Genetics
  • 12.5.1 Company Details
  • 12.5.2 Zika Vaccines Product Offered
  • 12.5.3 NewLink Genetics Zika Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.5.4 Main Business Overview
  • 12.5.5 NewLink Genetics News
• 12.6 Immunovaccine
  • 12.6.1 Company Details
  • 12.6.2 Zika Vaccines Product Offered
  • 12.6.3 Immunovaccine Zika Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.6.4 Main Business Overview
  • 12.6.5 Immunovaccine News
• 12.7 GlaxoSmithKline
  • 12.7.1 Company Details
  • 12.7.2 Zika Vaccines Product Offered
  • 12.7.3 GlaxoSmithKline Zika Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.7.4 Main Business Overview
  • 12.7.5 GlaxoSmithKline News

...

13 Research Findings and Conclusion

According to this study, over the next five years the Zika Vaccines market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2023, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Zika Vaccines business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Zika Vaccines market by product type, application, key manufacturers and key regions and countries.

This study considers the Zika Vaccines value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2023 in section 11.7.
Therapeutic Vaccines
Preventive Vaccines
Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2023 in section 11.8.
Hospitals
Clinics
Ambulatory Surgery Centers
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bharat Biotech
Inovio Pharmaceuticals
Cerus Corporation
Sanofi
NewLink Genetics
Immunovaccine
GlaxoSmithKline
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Zika Vaccines consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Zika Vaccines market by identifying its various subsegments.
Focuses on the key global Zika Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Zika Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Zika Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.